Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Leveling the Playing Field in Medicinal Chemistry

Posted on June 26th, 2017 by in Chemistry

For the designers and developers of Elsevier’s R&D Solutions, a major concern is ensuring that each solution makes the same level of searching or analytical power available to all users. The primary aim for the teams is to Continue reading “Leveling the Playing Field in Medicinal Chemistry” »

Broadening the Field of Research While Staying Focused

Posted on June 7th, 2017 by in Pharma R&D

Since joining The Hive, our team at Myelo Therapeutics has had the opportunity to train on and utilize a number of Elsevier’s information solutions, and they have already made a significant impact on our work, whether using Scopus to find collaborators or analyzing chemical structures with Reaxys. Continue reading “Broadening the Field of Research While Staying Focused” »

Predicting Adverse Event Risks and Gaining Insights from Disparate Data

Posted on May 17th, 2017 by in Pharma R&D

The upcoming Bio IT World Conference and Expo will feature two talks from Elsevier Life Sciences consultants, focusing on predicting adverse events in clinical trials and extracting knowledge from multiple data sets. Continue reading “Predicting Adverse Event Risks and Gaining Insights from Disparate Data” »

Avoiding the Risks of Being Wrong in Drug Discovery

Posted on May 5th, 2017 by in Pharma R&D

In a recent case study featuring a mid-market biopharma company, a pre-clinical research leader explains that in order to avoid the risks of being wrong when investigating potential new molecules Continue reading “Avoiding the Risks of Being Wrong in Drug Discovery” »

  1. 1
  2. 2
  3. 3
  4. …
  5. 8